Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

University of Calgary

$35,000.00

Targeting iron acquisition for prevention of disease in ruminants

FY 2014-15

Summary
This study is focused on bacteria that colonize the upper respiratory tract of cattle and other ruminants and are the primary cause of respiratory infections, including ?shipping fever?, which continues to be a major problem facing the cattle industry. Although there are a number of vaccines in use that are designed to prevent this infection, they have not substantially reduced the problem, primarily because they do not adequately deal with antigenic variation in the bacteria that cause the infection. To overcome this problem we plan to take advantage of a common trait that all these bacteria share, and ultimately develop improved vaccine antigens from the surface proteins that are common to these bacteria. The surface proteins that we propose to target are essential for acquiring iron for growth from the host iron binding protein, transferrin. Our first step is to determine the prevalence of these proteins in pathogens and related bacteria that colonize the upper respiratory tract and to obtain a detailed understanding of antigenic diversity of these proteins. The reason this is important is that if the proteins are present in other bacteria that colonize the upper respiratory tract, they may serve as a reservoir for antigenic variants that the pathogens could use to evade the vaccine. Comparison of the sequences of these proteins will be enhanced by the availability of the detailed three-dimensional structure of several of these proteins that our group has determined. The detailed understanding of the location and function of the variable regions of these proteins will provide the foundation for structure-based protein engineering for developing antigens with improved immunological properties. We also plan to use novel assays we developed to evaluate sera from immunized animals for their ability to protect against strains carrying the diverse set antigenic variants of the proteins. These assays will be useful for engineering improved and optimized vaccine antigens, and will provide a relatively inexpensive means of evaluating how cross-protective vaccines will be.
Program
Discovery Grants Program - Individual
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
RGPIN-2014-04198
Name nom
Schryvers, Anthony
Department département
Department of Microbiology, Immunology & Infectious Diseases
Organization id
11
Institution établissement
University of Calgary
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2014
Competition year année de concours
2014
Award amount
35000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
100
Area of application group en
Agriculture and primary food production
Area of application group fr
Agriculture et produits alimentaires primaires
Area of application en
Agriculture and primary food production
Area of application fr
Agriculture et produits alimentaires primaires
Research subject code
5201
Research subject group en
Microbiology
Research subject group fr
Microbiologie
Research subject en
Bacteriology
Research subject fr
Bactériologie
Partie
1
Nb partie
1
Application title
Targeting iron acquisition for prevention of disease in ruminants
Keyword
NSERC
Application summary
This study is focused on bacteria that colonize the upper respiratory tract of cattle and other ruminants and are the primary cause of respiratory infections, including ?shipping fever?, which continues to be a major problem facing the cattle industry. Although there are a number of vaccines in use that are designed to prevent this infection, they have not substantially reduced the problem, primarily because they do not adequately deal with antigenic variation in the bacteria that cause the infection. To overcome this problem we plan to take advantage of a common trait that all these bacteria share, and ultimately develop improved vaccine antigens from the surface proteins that are common to these bacteria. The surface proteins that we propose to target are essential for acquiring iron for growth from the host iron binding protein, transferrin. Our first step is to determine the prevalence of these proteins in pathogens and related bacteria that colonize the upper respiratory tract and to obtain a detailed understanding of antigenic diversity of these proteins. The reason this is important is that if the proteins are present in other bacteria that colonize the upper respiratory tract, they may serve as a reservoir for antigenic variants that the pathogens could use to evade the vaccine. Comparison of the sequences of these proteins will be enhanced by the availability of the detailed three-dimensional structure of several of these proteins that our group has determined. The detailed understanding of the location and function of the variable regions of these proteins will provide the foundation for structure-based protein engineering for developing antigens with improved immunological properties. We also plan to use novel assays we developed to evaluate sera from immunized animals for their ability to protect against strains carrying the diverse set antigenic variants of the proteins. These assays will be useful for engineering improved and optimized vaccine antigens, and will provide a relatively inexpensive means of evaluating how cross-protective vaccines will be.